medigraphic.com
ISSN 1561-3046 (Electronic)

2020, Number 3

<< Back Next >>

Rev Cub Med Mil 2020; 49 (3)

Bacterial infections associated with COVID-19 in patients of the Intensive Care Unit

Aguilera CY, Díaz MY, Ortiz DLA, Gonzalez MOL, Lovelle EOA, Sánchez ÁML

Language: Spanish
References: 13
Page:
PDF size: 257.23 Kb.


ABSTRACT

Introduction: The first reports from China suggested that coinfection with other pathogens in COVID-19 was abnormal, the latest evidence has shown that other infections may appear, especially in severe patients.
Objective: To describe the bacterial infections associated with COVID-19, in patients in an intensive care unit.
Methods: A descriptive study was carried out in the period from March 24 to May 24, 2020, in the intensive care unit of the Military Hospital "Comandante Manuel Fajardo Rivero". The study population consisted of 13 patients from 49 to 91 years, those who remained hospitalized in that room, with a confirmed diagnosis, by the real-time reverse transcriptase-polymerase chain reaction test for SARS-CoV-2. The study variables were: age, sex, clothing, personal pathological history, status at discharge, isolated microorganisms and antimicrobial susceptibility.
Results: 61.5% of the patients were female, the mean age was 78.8 years, 61.5% died, and among these, 44.4% had coinfection. 66.7% and 55.6% of those with high blood pressure and ischemic heart disease, respectively, developed a coinfection. Escherichia coli was the most frequently isolated microorganism.
Conclusions: Females predominated in the series studied, mortality was high, a high percentage of bacterial preparation and comorbidities was evident. More than half of the patients died. Gram-negative bacteria were the microorganisms that were most isolated. Antimicrobial resistance levels were high.


REFERENCES

  1. Guanche Garcell H. COVID-19. Un reto para los profesionales de la salud. Revista Habanera de Ciencias Médicas. 2020 [acceso. 17/05/2020];19(2):[aprox. 10 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3284

  2. Madrigal Rojas JP, Quesada Loría M, García Sánchez M, Solano Chinchilla A. SARS CoV-2, manifestaciones clínicas y consideraciones en el abordaje diagnóstico de COVID-19. Revista Médica de Costa Rica. 2020 [acceso: 17/05/2020];85(629):[aprox. 3 p.]. Disponible en: http://www.revistamedicacr.com/index.php/rmcr/article/viewFile/287/264

  3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 [acceso: 07/05/2020];395(10223): 507-513. Disponible en: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2820%2930211-7/fulltext#seccestitle150

  4. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 [acceso: 11/05/2020];579:270-3. Disponible en: https://doi.org/10.1038/s41586-020-2012-7

  5. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020[acceso: 11/05/2020];323(20):2085-6. Disponible en: http://scholar.google.com/scholar_url?url=https://jamanetwork.-com/journals/jama/articlepdf/2764787/jama_kim_2020_ld_200032.-pdf&hl=es&sa=T&oi=ucasa&ct=ufr&ei=Y9jCXqTAHPiLy9YP8KehmA-o&scisig=AAGBfm2hiKsZ6FMpE4himcrxSVDe56yXmA&nossl=1

  6. Monté Cerero L, Martínez Casanueva R. Microorganismos aislados en pacientes ingresados. Hospital "Salvador Allende", La Habana. Febrero a junio de 2015. Revista Habanera de Ciencias Médicas. 2017 acceso: 07/05/2020;16(4):aprox. 11 p. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/1326

  7. Díaz Medina LM, Medina García M, Duque González AC, Miguélez Nodarse R. Susceptibilidad antimicrobiana en muestras clínicas de pacientes con infecciones asociadas a la atención de salud. Revista Habanera de Ciencias Médicas. 2017 acceso: 07/05/2020;16(3):aprox. 14 p. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/1650

  8. González Castro A, Escudero Acha P, Peñasco Y, Leizaola A, Martínez de Pinillos Sánchez V, García de Lorenzo A. Cuidados intensivos durante la epidemia de coronavirus 2019. Medicina Intensiva. 2020. [acceso: 27/05/2020]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210569120300899

  9. Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Peru Med Exp Salud Pública. 2020[acceso: 29/05/2020];37(2):253-8. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/5437/3535

  10. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020[acceso: 26/05/2020]; 0954162(478):1-4. Disponible en: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa530/5828058

  11. Fernández Rodríguez A, Casas I, Culebras E, Morilla E, Cohen MC, Alberola J. COVID-19 y estudios microbiológicos post mortem. Revista Española de Medicina Legal. 2020[acceso: 26/05/2020];46(3):127-38. Disponible en: https://www.sciencedirect.com/science/article/pii/S037747322030030-4/pdf?md5=ec25ee2a89a69b3bd95fae7f52ebbcbe&pid=1-s2.0-S0377473220300304-main.pdf

  12. Kirchhelle C, Roberts A, Singer AC. Antibiotic Resistance Could Lead to More COVID-19 Deaths. Scientific American. 2020[acceso: 30/05/2020];2(2):[aprox. 8 pant.] Disponible en: https://blogs.scientificamerican.com/observations/antibiotic-resistance-could-lead-to-more-covid-19-deaths/

  13. Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C. German recommendations for critically ill patients with COVID 19. Med Klin Intensivmed Notfmed. 2020[acceso: 26/05/2020];1-4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155395/




2020     |     www.medigraphic.com